Oruka Therapeutics, Inc. ORKA Non Cash Lease Expense
Non Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept orka:NonCashLeaseExpense.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s non cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s non cash lease expense?
- Oruka Therapeutics, Inc. (ORKA) reported non cash lease expense of $143K in Q1 2026.
- What does non cash lease expense mean?
- Represents the portion of lease expenses that does not involve an immediate cash outflow, typically related to the amortization of right-of-use assets. This metric is used to reconcile net income to operating cash flow. It helps investors distinguish between actual cash expenditures and accounting charges related to long-term lease obligations.